Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL758739

N.N.N.N.N.N.[Cl-].[Cl-].[Co+2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Ammonia Solution, Strong. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220145346-A1 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS CAMENA BIOSCIENCE LIMITED (GB) 2022-05-12 US claimed
EP-3911757-A2 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS Camena Bioscience Limited (GB) 2021-11-24 EP claimed
US-20210087600-A1 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS CAMENA BIOSCIENCE LIMITED (GB) 2021-03-25 US claimed
EP-3737755-A1 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS Camena Bioscience Limited (GB) 2020-11-18 EP claimed
WO-2020150143-A2 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS CAMENA BIOSCIENCE LIMITED (GB) 2020-07-23 WO claimed
WO-2017218925-A1 MODIFIED 3' REGION EXTRACTION AND DEEP SEQUENCING OF POLYADENYLATION SITES AND POLY(A) TAIL LENGTH ANALYSIS RUTGENTS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2017-12-21 WO claimed
US-20170267998-A1 METHODS OF SYNTHESIZING POLYNUCLEOTIDES AXIOMX, INC. 2017-09-21 US claimed
US-20120309952-A1 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2012-12-06 US claimed
EP-1996730-A2 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2008-12-03 EP claimed
US-20080139800-A1 Process For the Concentration and/or Isolation of Nucleic Acid or Nucleic Acid-Containing Species QIAGEN GMBH (DE) 2008-06-12 US claimed
EP-0728211-B1 PROCESS OF PRODUCING HIGHLY TRANSFORMABLE BACTERIAL CELLS AND CELLS PRODUCED THEREBY STRATAGENE INC (US) 2001-05-16 EP claimed
EP-1005527-A1 HIGHLY TRANSFORMABLE BACTERIAL CELLS AND METHODS FOR PRODUCING THE SAME STRATAGENE (US) 2000-06-07 EP claimed
WO-1998049266-A1 HIGHLY TRANSFORMABLE BACTERIAL CELLS AND METHODS FOR PRODUCING THE SAME STRATAGENE (US) 1998-11-05 WO claimed
US-5707841-A Process of producing highly transformable bacterial cells and cells produced thereby STRATAGENE (US) 1998-01-13 US claimed
EP-0728211-A1 PROCESS OF PRODUCING HIGHLY TRANSFORMABLE BACTERIAL CELLS AND CELLS PRODUCED THEREBY STRATAGENE (US) 1996-08-28 EP claimed
US-5512468-A TRANSFERRING A GENE ENCODING AN ENZYME WITH CARBOHYDRATE DEGRADING ACTIVITY INTO E. COLI CELLS AND SUBSEQUENTLY RENDERING THE CELLS COMPETENT STRATAGENE (US) 1996-04-30 US claimed
WO-1995013388-A1 PROCESS OF PRODUCING HIGHLY TRANSFORMABLE BACTERIAL CELLS AND CELLS PRODUCED THEREBY STRATAGENE (US) 1995-05-18 WO claimed
EP-0212444-B1 PROCESS OF PRODUCING HIGHLY TRANSFORMABLE CELLS AND CELLS PRODUCED THEREBY LIFE TECHNOLOGIES INC. (US) 1992-03-25 EP claimed
US-4981797-A ESCHERICHIA FOR GENETIC ENGINEERING LIFE TECHNOLOGIES, INC. (US) 1991-01-01 US claimed
EP-0212444-A2 Process of producing highly transformable cells and cells produced thereby LIFE TECHNOLOGIES INC. (US) 1987-03-04 EP claimed